Evidence map›Paper›PMID 42215450›Full record

ArticleBlood cancer journal2026

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

Hyungwoo Cho, Koji Kato, Jason Yongsheng Chan, Kim Dajung, Haiwen Huang, Qingqing Cai, Tongyu Lin, Udomsak Bunworasate, Sen-Mui Tan, Ka-Won Kang and 24 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Hyungwoo Cho *Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0003-4307-2795
Koji Kato *Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Jason Yongsheng ChanDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4801-3703
Kim DajungDepartment of Internal Medicine, Kosin University College of Medicine, Busan, South Korea.ORCID http://orcid.org/0000-0003-2375-8140
Haiwen HuangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Qingqing CaiDepartment of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID http://orcid.org/0000-0001-5447-3282
Tongyu LinSichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science & Technology of China, Chengdu, China.
Udomsak BunworasateDivision of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Sen-Mui TanDepartment of Hematology, Ampang Hospital, Ampang, Selangor, Malaysia.
Ka-Won KangDepartment of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.ORCID http://orcid.org/0000-0003-1462-0502
Jae-Yong KwakDepartment of Internal Medicine, Jeonbuk National University Hospital, Jeonju, South Korea.ORCID http://orcid.org/0000-0002-8070-4002
Tsai-Yun ChenDivision of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Jeong-Ok LeeDivision of Hemato-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Seong Hyun JeongDepartment of Hematology-Oncology Ajou University School of Medicine, Suwon, South Korea.
Young Rok DoDepartment of Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea.
Esther ChanDepartment of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.
Hye Jin KangDepartment of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
Hyeon-Seok EomCenter for Hematologic Malignancies, National Cancer Center, Goyang, South Korea.
Sung Yong OhDepartment of Oncology, Dong-A University Hospital, Busan, South Korea.
Youngil KohDepartment of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Hyo Jung KimDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea.
Se-Hyung KimDepartment of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.
Jong Ho WonDepartment of Hematology-Oncology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, South Korea.
Young Hoon ParkDepartment of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, South Korea.
Deok Hwan YangDepartment of Hemato-Oncology, Chonnam National University Hwasun Hospital, Gwangju, South Korea.ORCID http://orcid.org/0000-0002-8167-8520
Soo Chin NgDepartment of Medicine University of Tunku Abdul Rahman, Selangor, Malaysia.
Jae-Cheol JoDepartment of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Hilman TadjoedinDepartment of Internal Medicine, Dharmais National Cancer Center, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Anna Mira LubisDivision of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Noorwati SutandyoDepartment of Internal Medicine, Dharmais National Cancer Center, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Tsuyoshi MutaDepartment of Transfusion Medicine, Hiroshima Red Cross Hospital, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-8305-9467
Ken TakaseDepartment of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Dok Hyun YoonDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. dhyoon@amc.seoul.kr.ORCID http://orcid.org/0000-0002-8289-3548
Won Seog KimDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. wskimsmc@skku.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42215450
PMCPMC13221449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.